| Characteristics |
N=74 |
| Age |
|
| < 40 |
24 (32%) |
| 40-50 |
40 (54%) |
| >50 |
10 (14%) |
| Menopause |
14 (19%) |
| Location |
| External quadrant |
50 (68%) |
| Internal quadrant |
14 (19%) |
| Clinical Tumor stage |
| T1 |
28 (38%) |
| T2 |
44 (59%) |
| Clinical Nods stage |
| N0 |
46 (62%) |
| N1 |
27 (37%) |
| Histological type |
| Invasive ductal carcrcinoma |
67 (90%) |
| Medullary carcinoma |
4 (5%) |
| SBR grade |
| SBR II |
32 (43%) |
| SBR III |
36 (49%) |
| Pathological Tumor stage |
| T1 |
26 (35%) |
| T2 |
40 (54%) |
| Pathological Nods stage |
| N0 |
35 (47%) |
| |
20 (27%) |
| Intraductal component |
28 (39%) |
| LVI + |
21 (28%) |
| ER/PR+ |
60 (81%) |
| Chemotherapy |
|
| Neoadjuvant |
2 (3%) |
| Adjuvant |
65 (88%) |
| Boost technics |
|
| Electrons |
28 (38%) |
| Brachytherapy |
28 (38%) |
| Phontons |
18 (24%) |
|
